the optimal sequencing of therapies in waldenström’s macroglobulinemia
Published 2 years ago • 118 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
3:40
master class in transplantation and hematology: highlights
-
1:47
unmet needs in wm: managing high-risk disease, sequencing novel agents, & personalizing treatment
-
4:15
diagnostic tools for wm and the importance of whole genome sequencing
-
1:17
the gem-optimal study: an observational study using alcyone-optimized real-world evidence data
-
28:13
stephen belanger | node.js observability with diagnostics_channel and asynclocalstorage
-
22:09
why therapy can leave you feeling worse
-
51:04
fault tolerance of stabilizer channels
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
2:09
advances in the management of fit adults with aml
-
5:07
daratumumab in the management of al amyloidosis
-
1:04
clad-ldac-ven induction therapy in aml: insights from a phase ii trial
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
0:41
isct in bringing together the scientific community
-
2:59
low-intensity venetoclax-based preconditioning followed by sequential allosct for r/r aml or hr-mds
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
1:10
the importance of incorporating patient-reported outcomes in clinical practice
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
4:15
using mrd to guide post-allosct treatment decisions in aml
-
0:52
the importance of incorporating frailty assessment tools in clinical practice for multiple myeloma